Obesity Market PowerPoint PPT Presentations

Get a sample brochure @ http://tinyurl.com/gn984fc This report studies Anti-Obesity Drugs in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with Production, price, revenue and market share for each manufacturer, covering

Get a sample brochure @ http://tinyurl.com/gn984fc This report studies Anti-Obesity Drugs in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with Production, price, revenue and market share for each manufacturer, covering

Get a sample brochure @ http://tinyurl.com/gn984fc This report studies Anti-Obesity Drugs in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with Production, price, revenue and market share for each manufacturer, covering

The report on Anti-Obesity Prescription Drugs Market by drug class (orlistat, phentermine and topiramate, bupropion and naltrexone, lorcaserin, liraglutide), distribution channel (retail pharmacy, hospital pharmacy and online pharmacy), age group (pediatric and adult) trends analysis and forecasts up to 2024 studies the market sizes, key trends and opportunities in the main geographies such as North America, Europe, Asia-Pacific, Rest of the World. According to the report the Global Anti-Obesity Prescription Drugs Market is projected to grow at a CAGR of 4.97% in terms of value over the period of 2018-2024. The growth in the world market is primarily driven by significant contribution by North America (Leading region) region to this market.

Obesity Treatment Market, By Procedure Type (Gastric Bypass, Gastric Banding, Non-Invasive Surgery, Sleeve Gastrectomy); By Products Type (Gastric Bands, Gastric Balloons, Stapling Devices, Gastric Electrical Stimulators); By Drug Type (Malabsorption & Satiety Drugs, Combination Drugs, Appetite Suppressants)]; and Geography - Trend, Analysis and Forecast

Obesity is an excess of body fat. It is difficult to directly measure body fat. In the context of China-US trade war and global economic volatility and uncertainty, it will have a big influence on this market. Obesity Treatment Report by Material, and Geography ? Global Forecast to 2025 is a professional and comprehensive research report on the world?s major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, Germany, United Kingdom, Japan, South Korea and China).

Read here the latest on the " Bicycle Market Analysis " published by CMI team

Read here the latest updates on the “Low Calorie Food Market” published by CMI team.

Global Obesity Surgery Devices Market size is projected to be valued $41 Billion by 2024; with a CAGR of 9.2% from 2017 to 2025. Obesity is mainly caused by increased fatty intake, reduced physical exercises, and genetic inherita

Global Obesity Surgery Devices Market size is projected to be valued $41 Billion by 2024; with a CAGR of 9.2% from 2017 to 2025. Obesity is mainly caused by increased fatty intake, reduced physical exercises, and genetic inherita

The global antiobesity market is expected to grow from $1.46 billion in 2020 to $2.4 billion in 2021 at a compound annual growth rate (CAGR) of 64.4%. The market is expected to reach $5.42 billion in 2025 at a CAGR of 22.6%.

A recent report published by Precision Business Insights on Obesity Treatment Market provides in-depth analysis of segments and sub-segments in the global as well as regional.

Read here the latest updates on the Liver Fibrosis Treatment Market published by the CMI team.

World Health Organization (WHO) suggests that over 50% of the worldwide population is obese. Furthermore, in the year 2014, over 1.9 billion adults that were 18 years and above were overweight. Out of these, more than 600 million were reported obese

This report studies Anti Obesity Drugs in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2013 to 2018, and forecast to 2025. This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering Pfizer Merck Roche GlaxoSmithKline AstraZeneca

For more information kindly visit : https://www.bharatbook.com/drugs-market-research-reports-396211/anti-obesity-drugs-china1.html Bharat Book Bureau provides the report, on “ Anti-Obesity Drugs Markets in China ”. China's demand for Anti-Obesity Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow.

The global obesity surgery device market is estimated at USD 1,432.4 million in 2014. It is likely to grow at a CAGR of 9.6% from 2014 to 2020 to reach USD 2,489.5 million in 2020.

The Global and Chinese Abdominal Obesity Drug Industry, 20132023 Market Research Report is a professional and indepth study on the current state of the global Abdominal Obesity Drug industry with a focus on the Chinese market. The report provides key statistics on the market status of the Abdominal Obesity Drug manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry.

Obesity Management Market: Phentermine and Topiramate Expected to be the Second Most Lucrative Segment by Drug Type: Global Industry Analysis and Opportunity Assessment 2017-2027

Big Market Research present “Global Anti-Obesity Drugs Market” Size, Share, Industry Trends, Demand, Insights, Analysis, Research, Report, Opportunities, Company Profiles, Forecast to 2019. Visit for more info @ http://www.bigmarketresearch.com/global-anti-obesity-drugs-2015-2019-market Obesity is a medical condition in which there is surplus accumulation of fat in the body. It is linked with increased illness risk, disability, and death. Although anti-obesity drugs are available in the market, their effectiveness is restricted to maintain weight rather than cure.

Persistence Market Research Released New Market Report on “Global Market Study on Obesity Surgery Devices: Asia-Pacific to Witness Highest Growth by 2020” the global obesity surgery devices market was valued at USD 1,432.4 million in 2014 and is expected to grow at a CAGR of 9.6% from 2014 to 2020, to reach an estimated value of USD 2,489.5 million in 2020.

Saudi Arabia Wellness Market Outlook to 2020 - Changing Demographics and Prevalence in Lifestyle Diseases will drive the Market" provides a comprehensive analysis of Wellness market in Saudi Arabia. The report covers various aspects such as market size of wellness market, market segmentation by wellness products & Services, fitness centers market size, spa/salon centers market size, personal care products market size, skin care market size

Laparoscopy is a minimally invasive operation in which abdominal or pelvic surgery is performed through a small incision. It has several advantages over laparotomy, which requires larger incisions. Laparoscopy uses TV images to examine and diagnose the condition of a disease or to carry out surgery. A rise in the obese population has resulted in laparoscopic surgeries being popularly used for weight reduction (bariatric surgeries). In-depth analysis of the global laparoscopy devices market focuses on various aspects of the market such as market trends, market drivers, restraints and opportunities. Competitive landscape section focuses on key leaders within the global laparoscopy devices market and their major growth strategies. Detailed analysis of segments helps in understanding market dynamics and would be beneficial for market professionals.

Obesity is a major growing health concern around the world. In most markets, a person is considered obese if their Body Mass Index (BMI) exceeds 30 kilograms per square meter (kg/m2), calculated by dividing body mass in kilograms by height in meters squared.

Persistence Market Research Released New Market Report on “Global Market Study on Obesity Surgery Devices: Asia-Pacific to Witness Highest Growth by 2020” the global obesity surgery devices market was valued at USD 1,432.4 million in 2014 and is expected to grow at a CAGR of 9.6% from 2014 to 2020, to reach an estimated value of USD 2,489.5 million in 2020.

The global Obesity Treatment Surgery Devices Market is highly fragmented due to the presence of a various large number of players which forms a competitive environment. The report entails all-inclusive information associated with the latest market updates such as new ideas, market size, opportunity, growth path and trends for the forecast period of 2019-2025 to gain competitive edge across the globe. This report also highlights various important strategic mergers and acquisitions, company overview, financial details, and the latest development undertaken.

Weight Loss Market & Obesity Management Market report categorizes the global market by Meal Replacements [Supplements, Foods & Beverages], Fitness & Surgical Equipments, Slimming Centers, Nutrition & Psychological Consultancy & by Geography"

The Global Obesity Surgery Devices Market Research Report 2017 provides a detailed Obesity Surgery Devices industry overview along with the analysis of industry’s gross margin, cost structure, consumption value and sale price. The key companies of the market, manufacturers, distributors along with the latest development trends and forecasts are detailed in the report.

Download Sample brochure@ http://tinyurl.com/goc3byx Marketintelreports, ‘Obesity - Pipeline Review, H2 2015’, provides an overview of the Obesity’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Obesity, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Obesity and special features on late-stage and discontinued projects.

Indonesia Pharmaceutical market has registered an increase in the revenue at a CAGR of ~% from USD ~ billion in 2012 to USD ~ billion in 2017. For more information on the research report, refer to below link: https://www.kenresearch.com/healthcare/pharmaceuticals/indonesia-pharmaceutical-market/143542-91.html

Cancer Test Market & Forecast, Companies Cancer Test Platform, Pipeline Analysis and Clinical Trials - Global @ http://www.reportsnreports.com/reports/276963-cancer-test-market-forecast-companies-cancer-test-platform-pipeline-analysis-and-clinical-trials-global.html Researcher study titled "Cancer Test Market & Forecast, Companies Cancer Test Platform, Pipeline Analysis and Clinical Trials - Global" provides a comprehensive assessment of the fast-evolving, high-growth of Cancer Test market segment. This 277 page report with 52 Figures and 57 Tables studies the Cancer Test Platform of 20 Companies. This report is broadly divided into 8 chapters.

Complete report is available @ http://goo.gl/UzUFeK . This report provides comprehensive information on the therapeutic development for Obesity, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Obesity and special features on late-stage and discontinued projects.

To Get sample Brochure now@ http://tinyurl.com/h6pzxkh A detailed qualitative analysis of the factors responsible for driving and restraining growth of the Europe Diabetic Shoes/Footwear Market and future opportunities are provided in the report.

The Anti-Obesity Drugs Industry 2015 report focuses on global major leading industry players providing information such as company profiles, product picture and specification, capacity, production, price, cost, revenue and contact information. Upstream raw materials and equipment and downstream demand analysis is also carried out.

Only one older generation drug with modest efficacy had been available until the recent arrival of two new therapies that could potentially change the prescribing landscape. Will these drugs make a significant impact on the Obesity market? Which drugs are used off-label for the treatment of obesity?

The increasing cases of coronary artery disease and diabetes coupled with growing obesity globally are driving the market growth. On top of that, growing awareness related to heart conditions, technological advancement in treatments, and rising numbers of hospitals and healthcare infrastructure around the globe have propelled the myocardial ischemia market expansion. Moreover, strong economic growth, disposable incomes of patients, and improved standard of living can fuel the market growth over the forecast period.

Big Market Research “Weight Loss and Weight Management Market” Size, Share, Industry Trends, Demand, Insights, Analysis, Research, Report, Opportunities, Company Profiles, Forecast to 2020. Visit for more info @ http://www.bigmarketresearch.com/weight-loss-and-weight-management-mnm-market The global weight loss and weight management market is expected to reach $206.4 billion by 2019 from $148.1 billion in 2014, growing at a CAGR of 6.9% from 2014 to 2019. The weight loss and weight management market is categorized on the basis of diets, equipment, and services.

Infusion Pumps & Accessories Market by Product (Volumetric, Syringe, Enteral, Insulin, Implantable, PCA Pump), Application (Diabetes, Chemotherapy, Nutrition, Pain Management) & by End-user (Hospital, Home Healthcare) - Global Forecasts to 2018 @ http://www.reportsnreports.com/reports/279651-infusion-pumps-accessories-market-by-product-volumetric-syringe-enteral-insulin-implantable-pca-pump-application-diabetes-chemotherapy-nutrition-pain-management-by-end-user-hospital-home-healthcare-global-forecasts-to-2018.html Infusion pumps and accessories have evolved from regular pumps to modern, automated, integrated, and flexible pumps to meet patient compliance requirements and also provide cost-effective treatment. The safety and quality of infusion pumps and accessories have also gained greater importance in the healthcare market over the years.

Glucose Monitoring Device Market to 2019 @ http://www.reportsnreports.com/reports/274855-glucose-monitoring-device-market-to-2019-technology-adoption-and-increasing-health-awareness-serve-as-distinct-regional-growth-drivers.html Researcher’s report, “Glucose Monitoring Device Market to 2019 Technology Adoption and Increasing Health Awareness Serve as Distinct Regional Growth Drivers” looks at the market, competitive landscape, and trends for the three glucose monitoring devices market segments: blood glucose meters, blood glucose testing strips, and lancets. The report provides comprehensive information on the key trends affecting these segments, and key analytical content on the market dynamics. It also reviews the competitive landscape and gives detailed analysis of each segment’s pipeline products, as well as details of important M&A deals.

The report on North America Obesity Surgery Devices Industry 2015 Market Research Reportadded by DecisionDatabases.com gives an in depth industry analysis of the market. It covers the costing, sales, revenue details and forecasts.

The world over, the high obesity rate has become a burden, and the dire need to bring it under control has risen as a result. World Health Organization (WHO) suggests that over 50% of the worldwide population is obese. Furthermore, in the year 2014, over 1.9 billion adults that were 18 years and above were overweight.

Infinium Global Research has added a new report on Global Anti-Obesity Prescription Drugs Market. The report predicts the market size of Anti-Obesity Prescription Drugs is expected to reach XX billion by 2024.

Obesity in the UK @ http://www.reportsnreports.com/reports/232666-obesity-in-the-uk.html The UK is among one of the fattest countries in the EU. In 2010 an estimated 63% of people aged 16 or over in England and 57% in Wales were classified as overweight or obese. In Scotland 63.3% of adults aged 16 to 64 were in that category. While the proportion of overweight people has not changed significantly, the proportion of obese people has increased by 11 percentage points since 1993. Overweight and obesity are steadily spreading in both the adult and the child populations across the UK.

The report on Compression Therapy Market by product(compression pump, compression bandage, compression stocking and compression tape), disease condition (lymphedema, VTE and others), technology(static, dynamic) trends analysis and forecasts up to 2023 studies the market sizes, key trends and opportunities in the main geographies such as North America, Europe, Asia-Pacific, Rest of the World. According to the report the Global Compression Therapy Market is projected to grow at a CAGR between 5.0% to 5.5% in terms of value over the period of 2017-2023. The growth in the world market is primarily driven by significant contribution by North America (Leading region) region to this market.

The report on Laparoscopic Devices Market by equipment (laparoscopes, energy systems, internal closure, trocars, insufflations, wound protectors, hand assist), application (general, colorectal surgeries, bariatric, gynecological, urological surgery), end user (hospitals, ambulatory surgical centers) trends analysis and forecasts up to 2023 studies the market sizes, key trends and opportunities in the main geographies such as North America, Europe, Asia-Pacific, Rest of the World. According to the report the Global Laparoscopic Devices Market is projected to grow at a CAGR of 7.2% in terms of value over the period of 2017-2023. The growth in the world market is primarily driven by significant contribution by North America (Leading region) region to this market.

The report on Metabolic Disorders Therapeutics Market by disease type (diabetes, obesity, hypercholesterolemia and lysosomal storage disease), product (metachromatic leukodystrophy, globoid leukodystrophy, hepatic encephalopathy and others) trends analysis and forecasts up to 2023 studies the market sizes, key trends and opportunities in the main geographies such as North America, Europe, Asia-Pacific, Rest of the World. According to the report the Global Metabolic Disorders Therapeutics Market is projected to grow at a CAGR of 5.7% in terms of value over the period of 2017-2023. The growth in the world market is primarily driven by significant contribution by North America (Leading region) region to this market.

The market is estimated to grow from around $2,385.9 million in 2013 to $3,073.9 million by 2018, at a CAGR of 5.5% from 2013 to 2018.

An extensive study of the product application and services conducted by subject matter experts assessing the market will help product owners to make a wise decision.

Major players in the Anti-obesity Drugs Market are F. Hoffmann-La Roche AG, GlaxoSmithKline PLC, Boehringer Ingelheim GmbH, and Pfizer Inc. Read More @ https://bit.ly/3t1IBZj

Major players in the Anti-obesity Drugs Market are F. Hoffmann-La Roche AG, GlaxoSmithKline PLC, Boehringer Ingelheim GmbH, and Pfizer Inc. Read More @ https://bit.ly/3t1IBZj

Rising prevalence of population with obesity and chronic diseases due to unhealthy lifestyle is key factor driving market growth whereas increasing awareness about consequences of increasing obesity and growing corporate wellness programs will also fuel market growth

Read here the latest updates on the Automated Suturing Devices Market published by the CMI team.

Bone Grafts and Substitutes Market Report, published by Allied Market Research, forecasts that the global market is expected to garner $3,397 million by 2022, registering a CAGR of 4.1% during the period 2016 - 2022. Bone graft substitutes segment dominated the overall market with a share of more than half of the overall market in 2015, and will continue to lead the market during the forecast period. Increase in musculoskeletal conditions, advancements in medical technology leading to a shift from autograft to allograft, increased preference for biocompatible bone grafts are key factors that contribute to the growth of the market worldwide. In addition, increase in cases of lifestyle disorders such as diabetes and obesity add to the risk of developing degenerative joint diseases that further fuel the growth of the market. Read more deatils at: https://www.alliedmarketresearch.com/bone-graft-substitutes-market

The rising influence of social media, increasing consumer consciousness towards physical appearance, and the elevating cases of obesity are primarily driving the GCC body contouring market. Furthermore, growing advancements in technologies, such as mesotherapy, infrared, dynamic pulse control (DPC), ultrasound cavitation, laser lipolysis, intense pulse light (IPL), etc., are also propelling the product demand. Besides this, the escalating awareness regarding cosmetic surgeries and the introduction of easy monthly installments (EMIs) for body contouring procedures are further augmenting the market growth. Read More: https://www.syndicatedanalytics.com/gcc-body-countering-market

Vital signs monitoring market size was worth $3,694 million in 2015 and is expected to reach $5,491 million by 2022, growing at a CAGR of 5.8% from 2016 to 2022. North America was the leading regional market in global vital signs monitoring devices industry. The blood pressure monitoring devices segment is expected to maintain its lead throughout the forecast period. Factors such asincrease in geriatric population, growth of inclination towards home monitoring, and rise in incidence rate of chronic diseases, such as cardiovascular disorders and obesity, are expected to drive the growth of the market. Moreover, introduction of innovative and technologically advanced digital blood pressure monitors and finger pulse oximeters is set to further drive the market growth. However, lack of awareness about these devices in low- and middle-income economies hampers the market growth. Read more details at: https://www.alliedmarketresearch.com/vital-signs-monitoring-market

The GCC bioactive ingredients market is primarily driven by the rising prevalence of chronic diseases, including cancer and various cardiovascular-related problems. Furthermore, sedentary consumer lifestyles and unhealthy food habits are resulting in a high occurrence of diabetes, obesity, etc. This has escalated the demand for functional and nutrient-rich food products that contain bioactive ingredients in the region.